Hesham El Ghazaly: Congrats Giuseppe Curigliano , joining as ESMO President-Elect 2025-2026

Giuseppe Curigliano shared a post by Hesham El Ghazaly, Professor of clinical Oncology at Ain Shams University, on LinkedIn:

“Thank you professor Hesham El Ghazaly to you personally and to all the community of Egyptian Onco-Hemathologists!”

Quoting Hesham El Ghazaly‘s post:

“Congrats Dear Friend Giuseppe Curigliano , joining the ESMO Executive Board on 1 January 2025 as President-Elect 2025-2026, ESMO President 2027-2028, and ESMO Past-President 2029-2030.
Elected ESMO President, well deserved achievement to a dedicated great scientist who has been always determined to make significant strides in improving cancer care globally , willing to see your distinguished impact, to further collaboration across boundaries especially in our countries in Middle East and Africa and the continued success of ESMO’s Initiatives .”

Source: Giuseppe Curigliano/LinkedIn and Hesham El Ghazaly/LinkedIn

Giuseppe Curigliano, MD, PhD, is the Director of  the Early Drug Development Division and co-chairs the Experimental Therapeutics Program at the European Institute of Oncology. He is a member of the Department of Oncology and Hemato-Oncology’s steering committee at the University of Milan and serves on the Italian National Health Council, advising the Ministry of Health on cancer policy issues.